Article
A Systematic Multi-LLM AI Framework for Immunotherapy Biomarker Discovery and Target Identification
2025-06-15
Abstract excerpt
<h4>ABSTRACT</h4> Immune checkpoint inhibitors have revolutionized cancer therapy, yet their efficacy is frequently limited by primary and acquired resistance. This underscores the need for novel immune regulatory targets that can improve or broaden patient responsiveness to immunotherapy. Among these, immunoglobulin (Ig) domain-containing proteins play central roles in immune signaling and tumor immune evasion,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c48f0c0b-843d-525c-be88-3a70ec32be94
- DOI
- 10.1101/2025.06.10.658988
